Azitra Inc (AZTR) Stock Price

AZTRStock

$0.16−83.71%52W

Market Cap$9.55M

P/E—

PEG Ratio—

Div yield—

Beta-1.10

AZTR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-20.64%

Price vs S&P 500 (4W)12.55%

VGM Score18.84

Book Value / Share (Quarterly)$0.65

P/TBV (Annual)0.82x

Revenue Growth (3Y)-59.15%

Cash Flow / Share (Quarterly)$-0.66

Price vs S&P 500 (YTD)-55.16%

Net Profit Margin (TTM)-1721.97%

EPS (TTM)$-2.06

10-Day Avg Trading Volume1.63M

EPS Excl Extra (TTM)$-2.06

EPS (Annual)$-2.25

ROI (Annual)-273.18%

Net Profit Margin (5Y Avg)-26947.34%

Cash / Share (Quarterly)$0.62

ROA (Last FY)-218.00%

EBITD / Share (TTM)$-1.33

ROE (5Y Avg)-197.36%

Operating Margin (TTM)-1772.18%

Cash Flow / Share (Annual)$-1.05

P/B Ratio0.22x

P/B Ratio (Quarterly)0.36x

Net Income / Employee (Annual)$-842,700

EV / Revenue (TTM)-18.81x

Net Interest Coverage (TTM)-66.81x

ROA (TTM)-178.15%

EPS Incl Extra (Annual)$-2.25

Current Ratio (Annual)2.83x

Quick Ratio (Quarterly)6.59x

3-Month Avg Trading Volume8.46M

52-Week Price Return-83.71%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.63

P/S Ratio (Annual)302.26x

Asset Turnover (Annual)0.00x

52-Week High$1.40

Operating Margin (5Y Avg)-32140.94%

EPS Excl Extra (Annual)$-2.25

CapEx CAGR (5Y)-35.68%

26-Week Price Return-9.40%

Quick Ratio (Annual)2.07x

13-Week Price Return-29.06%

Total Debt / Equity (Annual)0.06x

Current Ratio (Quarterly)6.94x

Enterprise Value$-7.68M

Asset Turnover (TTM)0.07x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-119446.13%

Cash / Share (Annual)$0.19

3-Month Return Std Dev115.45%

Net Income / Employee (TTM)$-606,700

ROE (Last FY)-288.21%

Net Interest Coverage (Annual)-66.64x

EPS Basic Excl Extra (Annual)$-2.25

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-2.06

Receivables Turnover (Annual)0.00x

ROI (TTM)-267.46%

P/S Ratio (TTM)5.55x

Pretax Margin (5Y Avg)-26922.75%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.32

Price vs S&P 500 (52W)-102.02%

Year-to-Date Return-43.20%

5-Day Price Return20.32%

EPS Normalized (Annual)$-2.25

ROA (5Y Avg)-159.41%

Net Profit Margin (Annual)-119566.53%

Month-to-Date Return13.34%

Cash Flow / Share (TTM)$-1.76

EBITD / Share (Annual)$-2.22

Operating Margin (Annual)-146468.53%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-190.52%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-2.06

P/TBV (Quarterly)0.37x

P/B Ratio (Annual)0.75x

Pretax Margin (TTM)-1717.73%

Book Value / Share (Annual)$0.35

Price vs S&P 500 (13W)-31.85%

Beta-1.10x

Revenue / Share (TTM)$0.00

ROE (TTM)-284.75%

52-Week Low$0.10

mGradeF

vgmGradeF

AZTR Earnings Surprise History

Q2 25-1.20est. -1.40

Q3 25-0.67est. -0.78

Q4 25-1.17est. -0.33

Q1 26-0.25est. -0.04

Q2 26-0.17est. -0.23

AZTR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
AZTRAzitra Inc	—	—	F	$0.16
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Azitra Inc

Azitra Inc is a clinical-stage biopharmaceutical company developing engineered microbial and protein therapeutics for rare dermatological diseases. Its proprietary platform identifies and genetically engineers naturally occurring bacteria to create live biotherapeutics, recombinant proteins, and small molecules for precision skin disease treatment. The company's pipeline includes ATR-12 for Netherton syndrome, ATR-04 for papulopustular rash, and ATR-01 for ichthyosis vulgaris.